Bootstrap Europe Expands to Africa: Unlocking Growth Potential with $270m Debt Fund
Bootstrap Europe, a renowned growth debt fund, has announced its expansion into Africa, launching a dedicated franchise to support the...
Latest Post
Growth4Her: Applications open for Women-Led Businesses Empowerment
The Growth4Her Accelerator program has launched its application process in Nigeria, offering women-led businesses a unique opportunity to scale and...
Stunning Decline of Globacom: Nigeria’s Third Biggest Telco Loses Ground
Nigeria's telecommunications landscape has witnessed a remarkable shift in recent years, with Globacom, once a dominant player, experiencing a stunning...
BioNTech Seals $800M Deal to Acquire Potential Keytruda Rival
In a strategic move to bolster its oncology pipeline, German biotechnology company BioNTech has acquired an innovative cancer therapy from...
Hidden Data on Obesity Drug Sends Amgen’s Market Value Plummeting by $12 Billion
In a stunning reversal of fortune, biotechnology giant Amgen Inc. suffered a staggering $12 billion loss in market capitalization after...
FDA Deals Another Blow to Kezar’s Zetomipzomib Program
The US Food and Drug Administration (FDA) has placed a second clinical hold on Kezar Life Sciences' zetomipzomib program in...
Senegal’s Green Revolution: A $2.7 Billion Commitment
Senegal has made a significant commitment to transitioning to a low-carbon economy with the launch of a $2.7 billion Green...
MultiChoice Nigeria’s Subscriber Decline
The Nigerian pay-TV market has experienced significant changes in recent times, with MultiChoice Nigeria, a leading player, facing a notable...
Starlink’s Chad Venture: Bridging the Digital Divide through Satellite Internet
In a groundbreaking move, Starlink, SpaceX's pioneering satellite internet constellation, has secured approval to revolutionize Chad's digital landscape. This development...
Novartis Signs $150M Deal with Schrödinger to Advance Drug Discovery Programs
Pharmaceutical giant Novartis has entered a strategic partnership with Schrödinger, paying $150 million for access to the company's innovative drug...
